RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      비미란성 역류 질환 = Nonerosive Reflux Disease

      한글로보기

      https://www.riss.kr/link?id=A100268983

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Nonerosive reflux disease (NERD) is a distinct presentation of gastroesophageal reflux disease (GERD). NERD is commonlydefined as the presence of classical GERD symptoms in the absence of esophageal mucosal erosions/breaks on upper endoscopy. Within the spectrum of GERD, the pathophysiological and clinical characteristics distinguishing NERD and erosive esophagitis remaina matter for debate. Recent research on NERD has focused on understanding the pathophysiology and natural history. Giventhe increased incidence of NERD in Korea, we reviewed the concept of NERD and its relationship to GERD and functional gastrointestinaldisorders.
      번역하기

      Nonerosive reflux disease (NERD) is a distinct presentation of gastroesophageal reflux disease (GERD). NERD is commonlydefined as the presence of classical GERD symptoms in the absence of esophageal mucosal erosions/breaks on upper endoscopy. Within t...

      Nonerosive reflux disease (NERD) is a distinct presentation of gastroesophageal reflux disease (GERD). NERD is commonlydefined as the presence of classical GERD symptoms in the absence of esophageal mucosal erosions/breaks on upper endoscopy. Within the spectrum of GERD, the pathophysiological and clinical characteristics distinguishing NERD and erosive esophagitis remaina matter for debate. Recent research on NERD has focused on understanding the pathophysiology and natural history. Giventhe increased incidence of NERD in Korea, we reviewed the concept of NERD and its relationship to GERD and functional gastrointestinaldisorders.

      더보기

      참고문헌 (Reference)

      1 이준행, "위식도역류질환의 치료에 관한 임상진료지침" 대한소화기학회 57 (57): 57-66, 2011

      2 조유경, "위식도역류질환의 진단: 체계적인 문헌고찰" 대한소화기학회 55 (55): 279-295, 2010

      3 이준행, "위식도 역류질환의 내시경 진단에서 관찰자 간 차이" 대한소화기내시경학회 33 (33): 197-203, 2006

      4 황진기, "국내 2-3차 의료기관에서 관찰된 미란 식도염의 유병률 및 증상 분포" 대한소화기학회 53 (53): 283-291, 2009

      5 유승석, "건강진단검사 수진자에서 식도질환의 유병률" 대한소화기학회 50 (50): 306-312, 2007

      6 Gerson LB, "Triadafilopoulos G. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease" 95 : 395-407, 2000

      7 El-Serag HB, "Time trends of gastroesophageal reflux disease:a systematic review" 5 : 17-26, 2007

      8 Kim N, "The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea" 27 : 173-185, 2008

      9 Drossman DA, "The functional gastrointestinal disorders and the Rome II process" 45 (45): II1-II5, 1999

      10 Shapiro M, "The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups" 23 : 321-329, 2006

      1 이준행, "위식도역류질환의 치료에 관한 임상진료지침" 대한소화기학회 57 (57): 57-66, 2011

      2 조유경, "위식도역류질환의 진단: 체계적인 문헌고찰" 대한소화기학회 55 (55): 279-295, 2010

      3 이준행, "위식도 역류질환의 내시경 진단에서 관찰자 간 차이" 대한소화기내시경학회 33 (33): 197-203, 2006

      4 황진기, "국내 2-3차 의료기관에서 관찰된 미란 식도염의 유병률 및 증상 분포" 대한소화기학회 53 (53): 283-291, 2009

      5 유승석, "건강진단검사 수진자에서 식도질환의 유병률" 대한소화기학회 50 (50): 306-312, 2007

      6 Gerson LB, "Triadafilopoulos G. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease" 95 : 395-407, 2000

      7 El-Serag HB, "Time trends of gastroesophageal reflux disease:a systematic review" 5 : 17-26, 2007

      8 Kim N, "The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea" 27 : 173-185, 2008

      9 Drossman DA, "The functional gastrointestinal disorders and the Rome II process" 45 (45): II1-II5, 1999

      10 Shapiro M, "The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups" 23 : 321-329, 2006

      11 Fass R, "Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease–where next?" 22 : 79-94, 2005

      12 Drossman DA, "Rome III: new standard for functional gastrointestinal disorders" 15 : 237-241, 2006

      13 Emerenziani S, "Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease" 21 : 253-258, 2009

      14 Ho KY, "Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the Western hemisphere" 94 : 1186-1191, 1999

      15 Labenz J, "Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease" 101 : 2457-2462, 2006

      16 Heading RC, "Prevalence of upper gastrointestinal symptoms in the general population: a systematic review" 231 : 3-8, 1999

      17 Mishima I, "Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese" 40 : 1005-1009, 2005

      18 Locke GR 3rd, "Prevalence and clinical spectrum of gastroesophageal reflux:a population-based study in Olmsted County, Minnesota" 112 : 1448-1456, 1997

      19 Hirano I, "Practice Parameters Committee of the American College of Gastroenterology" 102 : 668-685, 2007

      20 Frazzoni M, "Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease: Spectrum disease or distinct phenotypic presentations?" 38 : 643-648, 2006

      21 Lind T, "On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis-a placebo-controlled randomized trial" 13 : 907-914, 1999

      22 Martinez SD, "Non-erosive reflux disease (NERD)-acid reflux and symptom patterns" 17 : 537-545, 2003

      23 Martinez SD, "Non-erosive reflux disease (NERD)-acid reflux and symptom patterns" 17 : 537-545, 2003

      24 Ruigómez A, "Natural history of gastro-oesophageal reflux disease diagnosed in general practice" 20 : 751-760, 2004

      25 Nakamura T, "Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis" 21 (21): 19-26, 2005

      26 Wileman SM, "Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults" 3 : CD003243-, 2010

      27 Ang D, "Mechanisms of heartburn" 5 : 383-392, 2008

      28 Takubo K, "Is there a set of histologic changes that are invariably reflux associated?" 129 : 159-163, 2005

      29 Lv J, "Investigation of relationships among gastroesophageal reflux disease subtypes using narrow band imaging magnifying endoscopy" 19 : 8391-8397, 2013

      30 Lee YC, "Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging" 66 : 230-236, 2007

      31 Ronkainen J, "High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report" 40 : 275-285, 2005

      32 Lind T, "Heartburn without oesophagitis:efficacy of omeprazole therapy and features determining therapeutic response" 32 : 974-979, 1997

      33 Katz PO, "Guidelines for the diagnosis and management of gastroesophageal reflux disease" 108 : 308-328-quiz 329, 2013

      34 Vakil N, "Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus" 101 : 1900-1943, 2006

      35 Quigley EM, "Getting categorical on GERD" 102 : 1130-, 2007

      36 Fass R, "Gastroesophageal reflux disease-should we adopt a new conceptual framework?" 97 : 1901-1909, 2002

      37 Carlsson R, "Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD study group" 10 : 119-124, 1998

      38 Kaminski DL, "Evaluation of the use of the median arcuate ligament in fundoplication for reflux esophagitis" 134 : 724-729, 1977

      39 Zerbib F, "Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy" 101 : 1956-1963, 2006

      40 van Malenstein H, "Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease" 103 : 1021-1028, 2008

      41 Dent J, "Epidemiology of gastro-oesophageal reflux disease: a systematic review" 54 : 710-717, 2005

      42 Fass R, "Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease" 98 (98): S2-S7, 2003

      43 Lundell LR, "Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification" 45 : 172-180, 1999

      44 Dean BB, "Effectiveness of proton pump inhibitors in nonerosive reflux disease" 2 : 656-664, 2004

      45 Emerenziani S, "Effect of oesophagitis on proximal extent of gastro-oesophageal reflux" 19 : 459-464, 2007

      46 Fujiwara Y, "Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan" 100 : 754-758, 2005

      47 Bredenoord AJ, "Determinants of perception of heartburn and regurgitation" 55 : 313-318, 2006

      48 Zerbib F, "Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors" 57 : 156-160, 2008

      49 Chen CL, "Current advances in the diagnosis and treatment of nonerosive reflux disease" 2013 : 653989-, 2013

      50 Farré R, "Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces" 56 : 1191-1197, 2007

      51 Dickman R, "Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD)groups" 101 : 2463-2469, 2006

      52 Okamoto K, "Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects" 48 : 2237-2241, 2003

      53 Cameron AJ, "Barrett's esophagus: prevalence and size of hiatal hernia" 94 : 2054-2059, 1999

      54 Kotzan J, "Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a medicaid population" 18 : 1367-1372, 2001

      55 Dent J, "An evidence-based appraisal of reflux disease management-the Genval workshop report" 44 : S1-S16, 1998

      56 Bredenoord AJ, "Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy" 101 : 453-459, 2006

      57 Sharma P, "A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease" 133 : 454-464, 2007

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 계속평가 신청대상 (계속평가)
      2021-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2018-12-01 평가 등재후보 탈락 (계속평가)
      2017-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2013-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-05-15 학술지명변경 외국어명 : Korean Journal of Medicine -> The Korean Journal of Medicine KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.1
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.11 0.1 0.259 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼